DxTerity Diagnostics, a provider of genomic testing solutions, has developed NEAT, a genomic testing platform that replaces expensive enzymatic amplification techniques with a robust chemical reaction, enabling the development of simple and affordable diagnostic tests.

The contract started in December 2007 and proceeded in phases with periodic deliveries until July 2008. After the initial requirements were provided by DxTerity, an extensive analysis was done by the PREMIER Biosoft team, consisting of a panel of domain experts and software engineers. The highlights of the project included developing the algorithms required for the analysis and designing the user interface for making the product both easy-to-use and comprehensive.

The scope of the project included designing a complete NEAT probe design module that adhered to the DxTerity probe design guidelines. For mutation specific probe design, algorithms were developed not only to reduce assay costs, but also to enable efficient mutation detection. This was achieved by designing the probe set such that one probe was common for the mutation and wild type detection.

For details about the project, please visit: http://www.premierbiosoft.com/services/DxTerity.pdf 

About PREMIER Biosoft International:

Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Recently, the company has completed several custom software development contracts including one for PrimerDesign Ltd. Additional information about PREMIER Biosoft International can be found at http://www.PremierBiosoft.com